Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized StudyDaniel R. Gomez, John V. Heymach, Rong Ye et al.|Journal of Clinical Oncology|2019Cited by 1.3k
Single-Fraction Stereotactic vs Conventional Multifraction Radiotherapy for Pain Relief in Patients With Predominantly Nonspine Bone MetastasesQuynh‐Nhu Nguyen, Valerae O. Lewis, Stephen G. Chun et al.|JAMA Oncology|2019Cited by 226
The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cellsJames W. Welsh, Baldassarre Stea|Radiation Oncology|2009Cited by 114
Combination treatment with radiotherapy and a novel oxidative phosphorylation inhibitor overcomes PD-1 resistance and enhances antitumor immunityDawei Chen, James W. Welsh|Journal for ImmunoTherapy of Cancer|2020Cited by 93
Bone morphogenetic protein 7 promotes resistance to immunotherapyMaría Angélica Cortez, James W. Welsh|Nature Communications|2020Cited by 58